About S.C MedLife S.A
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at S.C MedLife S.A
During the past decade, S.C MedLife S.A conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 11 clinical trials were completed, i.e. on
average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 11 clinical trials were completed. i.e. 157.1%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "S.C MedLife S.A" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials
sponsored, "Pfizer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "AstraZeneca"
with 2 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "S.C MedLife S.A"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at S.C MedLife S.A
According to Clinical.Site data, the most researched conditions in "S.C MedLife S.A" are
"Crohn's Disease" (5 trials), "Ulcerative Colitis" (5 trials), "Crohn Disease" (3 trials), "Advanced or Inoperable Gastric Cancer" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "S.C MedLife S.A" in a lesser frequency.
Clinical Trials Intervention Types at S.C MedLife S.A
Most popular intervention types in "S.C MedLife S.A" are "Drug" (21 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Etrasimod" (4 trials), "Etrolizumab" (4 trials), "Mirikizumab" (3 trials) and "GED-0301" (2 trials). Other intervention names were less common.
Clinical Trials Genders at S.C MedLife S.A
The vast majority of trials in "S.C MedLife S.A" are
21 trials for "All" genders.
Clinical Trials Status at S.C MedLife S.A
Currently, there are NaN active trials in "S.C MedLife S.A".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in S.C MedLife S.A,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in S.C MedLife S.A, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of S.C MedLife S.A
S.C MedLife S.A has several departments that took part in Clinical trials: "MedLife, Gastroenterologie" - 4 trials